Dual-phase 18F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan-Reference-Cited by-同舟云学术

Dual-phase 18F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan

Published:2016-05 Issue:3 Volume:40 Page:486-491
ISSN:0899-7071
Container-title:Clinical Imaging
language:en
Short-container-title:Clinical Imaging

Author:

Tong Aaron Kian Ti^ORCID,Zhang Zoe Xiaozhu,Zaheer Sumbul,Yan Xuexian Sean

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference32 articles.

1. Epidemiology of prostate cancer;Bashir;Asian Pac J Cancer Prev,2015

2. Current controversies in the management of biochemical failure in prostate cancer;Bruce;Clin Adv Hematol Oncol,2012

3. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition;Stephenson;J Clin Oncol,2006

4. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

5. Imaging prostate cancer: a multidisciplinary perspective;Hricak;Radiology,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estandarización de los protocolos de adquisición mediante PET/TC con 18F-Colina en el cáncer de próstata;Revista Española de Medicina Nuclear e Imagen Molecular;2020-07

2. Standardization of acquisition protocols using PET/CT with 18F-Choline in prostate cancer;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2020-07

3. Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why;Tumori Journal;2019-05-16

4. Digital vs. analog PET/CT: intra-subject comparison of the SUVmax in target lesions and reference regions;European Journal of Nuclear Medicine and Molecular Imaging;2019-01-07

5. Cancers de la prostate;Médecine Nucléaire;2019-01